Turning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives

Area of Science:

• Hepatology
• Oncology
• Cancer Stem Cell Biology

Background:

• Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with poor treatment outcomes.
• Tumor heterogeneity, chemoresistance, and relapse are significant challenges in HCC management.
• Cancer stem cells (CSCs) are increasingly recognized as key drivers of HCC malignancy.

Purpose of the Study:

• To review recent findings on hepatic cancer stem cells (CSCs).
• To explore the origins, regulation, and therapeutic targeting of hepatic CSCs in HCC.
• To discuss the role of signaling pathways and the tumor microenvironment in hepatic CSC stemness.

Main Methods:

• Literature review of recent research on hepatic CSCs.
• Analysis of signaling pathways regulating CSC properties.
• Examination of the tumor microenvironment's influence on CSCs.
• Discussion of novel therapeutic strategies targeting hepatic CSCs.

Main Results:

• Hepatic CSCs possess self-renewal and differentiation capabilities, contributing to tumorigenicity and chemoresistance.
• Signaling pathways and tumor microenvironment interactions critically regulate hepatic CSC stemness.
• Hepatitis viruses may influence hepatic CSC properties and HCC development.
• Novel therapeutic strategies targeting hepatic CSCs show promise for combating HCC.

Conclusions:

• Hepatic CSCs are crucial players in HCC development, progression, and treatment resistance.
• Understanding the regulation of hepatic CSCs offers new avenues for HCC therapy.
• Targeting hepatic CSCs represents a promising strategy to improve outcomes for HCC patients.